Tom Palermo
Keine laufenden Positionen mehr
Profil
Thomas J.
Palermo served as the Chief Executive Officer at ReVascular Therapeutics, Inc. and Ulcerx Medical, Inc. He also worked as the Vice President of Operations & Engineering at Ensure Medical, Inc. Palermo was the Chief Operating Officer at Dextera Surgical, Inc. from 2015 to 2018.
He completed his undergraduate degree from Southern New Hampshire University.
Ehemalige bekannte Positionen von Tom Palermo
| Unternehmen | Position | Ende |
|---|---|---|
| DEXTERA SURGICAL INC | Geschäftsführer | 01.03.2018 |
Ensure Medical, Inc.
 Ensure Medical, Inc. Medical SpecialtiesHealth Technology Ensure Medical, Inc is a privately held company that develops devices for postcatheterization closure of the femoral artery. Its technology is based on a biodegradable closure device and a delivery system. The company was incorporated in 2002 and is headquartered in Sunnyvale, CA. | Geschäftsführer | - |
| Ulcerx Medical, Inc. | Vorstandsvorsitzender | - |
ReVascular Therapeutics, Inc.
 ReVascular Therapeutics, Inc. Medical SpecialtiesHealth Technology ReVascular Therapeutics, Inc. used to develop and manufacture medical devices. It offers TRUEPATH, an intraluminal chronic total occlusion crossing device enabling endovascular treatment in cases that typically cannot be treated with standard endovascular devices. The company was founded in 2006 by Carl Simpson, Menahem Nassi and Gerardo V. Noriega and is headquartered in Sunnyvale, CA. | Vorstandsvorsitzender | - |
Ausbildung von Tom Palermo
| Southern New Hampshire University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Ensure Medical, Inc.
Ensure Medical, Inc. Medical SpecialtiesHealth Technology Ensure Medical, Inc is a privately held company that develops devices for postcatheterization closure of the femoral artery. Its technology is based on a biodegradable closure device and a delivery system. The company was incorporated in 2002 and is headquartered in Sunnyvale, CA. | Health Technology |
ReVascular Therapeutics, Inc.
ReVascular Therapeutics, Inc. Medical SpecialtiesHealth Technology ReVascular Therapeutics, Inc. used to develop and manufacture medical devices. It offers TRUEPATH, an intraluminal chronic total occlusion crossing device enabling endovascular treatment in cases that typically cannot be treated with standard endovascular devices. The company was founded in 2006 by Carl Simpson, Menahem Nassi and Gerardo V. Noriega and is headquartered in Sunnyvale, CA. | Health Technology |
Dex Liquidating Co.
 Dex Liquidating Co. Medical SpecialtiesHealth Technology Dextera Surgical, Inc. designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. It specializes in robotic-assisted surgery and medical devices. The company was founded by Bernard A. Hausen and Stephen A. Yencho on October 15, 1997 and is headquartered in Pleasanton, CA. | Health Technology |
| Ulcerx Medical, Inc. |
